Designed for developers of medicinal products and other similarly regulated technologies. Receive advice from NICE and various other European Health...
Our procedures and policies - includes complaints, declarations of interest and data protection policies.
Advises NICE on the formulation of its guidance on the safety and efficacy of interventional procedures.
Evidence-based recommendations on the SepsiTest assay for rapidly identifying bloodstream bacteria and fungi
Jobs at NICE. Includes current vacancies, roles, location and salary information.
NICE diagnostics assessment recommendations are prepared by an independent advisory committee called the diagnostics advisory committee. Standing...
Advice from NICE to help you generate evidence to inform future NICE evaluations and to enable market access
Scientific advice case studies
Now we've left the European Union we can no longer offer the parallel advice service with the European Medicines Agency (EMA) via the European Network
Scientific advice for developers of pharmaceuticals
Evidence-based recommendations on peginterferon beta-1a (Plegridy) for treating relapsing–remitting multiple sclerosis in adults
NICE has developed a medtech innovation briefing (MIB) on National Early Warning Score systems that alert to deteriorating adult patients in hospital
Everything NICE has said on effective antimicrobial medicine use and preventing the spread of resistant microbes in an interactive flowchart
Everything NICE has said on the recognition, diagnosis and early management of sepsis in an interactive flowchart
Everything NICE has said on diagnosing and managing community- and hospital-acquired pneumonia in an interactive flowchart
Everything NICE has said on preventing, identifying and managing neutropenic sepsis in children, young people and adults in an interactive flowchart
Everything NICE has said on multiple sclerosis in an interactive flowchart
Biographies and interests register for the indicator advisory committee
The NICE scientific advice team
NICE transparency of spend
Details, meeting dates and minutes of the independent technology appraisal committees
Everything NICE has said on identifying, treating and managing depression in children, young people and adults in an interactive flowchart
The information below provides a summary of known issues and upcoming changes related to NICE Evidence Services. This information will be updated...
Axonics SNS has potential to save the NHS around £6,200 per patient if the device lasts more than six years
NICE quality standards set out priority areas for quality improvement in health and social care.
NICE research projects and partners.
The Quality Standards Advisory Committees (QSAC) are independent committees that help to develop our quality standards . We have 3 committees who:
How we select the subjects for development into information, advice and guidance
Evidence-based antimicrobial prescribing guidance for primary and secondary care with a focus on bacterial infection and antibiotic use.
NICE's impact on dementia referral, diagnosis and care planning
How NICE's guidance has impacted on supporting carers of adults with dementia
Evidence based recommendations on patiromer (Veltassa) for treating hyperkalaemia in adults
Everything NICE has said on diagnosing and managing chronic heart failure in adults in an interactive flowchart
Everything NICE has said on chronic kidney disease (renal failure) in an interactive flowchart
This guideline covers diagnosing, monitoring and managing asthma in adults, young people and children. It aims to improve the accuracy of diagnosis, help people to control their asthma and reduce the risk of asthma attacks. It does not cover managing severe asthma or acute asthma attacks.
Applications close on Wednesday 4 March 2020
We’re looking for a director to lead our new science, evidence and analytics function.
To help people access the information they need quickly and easily, we're reviewing how we produce and present guidance.
A quick and easy-to-read guide for care home managers about achieving good oral health in care homes.
Evidence-based recommendations on dapagliflozin (Forxiga) with insulin for treating type 1 diabetes not controlled by insulin therapy alone in adults with a
Evidence-based recommendations on sotagliflozin with insulin for treating type 1 diabetes in adults with a body mass index (BMI) of at least 27 kg/m2
Everything NICE has said on antenatal and postnatal mental health in an interactive flowchart
Everything NICE has said on diagnosing and managing type 1 diabetes in adults in an interactive flowchart
Everything NICE has said on diagnosing, monitoring and managing asthma in children, young people and adults in an interactive flowchart